GSK Investigational Site

Braunschweig, Lower Saxony 38126

0 studies enrolling now · 4 studies all time

What they study most

Crohn's Disease, Lung Cancer, Non-Small Cell, Nausea and Vomiting, Chemotherapy-Induced, Neoplasms, Prostate

Studies at this site

• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting. — Completed
• A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed